Christopher Peetz, President and CEO at Mirum Pharmaceuticals, Inc. (MIRM), sold 10,996 shares at $25.65 ($282K) on 2023-07-03, disclosed to the SEC on 2023-07-05.
Open-market sale of $282k MIRM by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.65 | 5,498 | $141K | 50.0% |
| 2 | $25.65 | 5,498 | $141K | 50.0% |
| Total | $25.65 avg | 10,996 | $282K | 100% |
| Filing → |
| MIRM | SELL | 2026-07-08 | $2.4M | — | Filing → |
| MIRM | SELL | 2026-06-02 | $2.9M | — | Filing → |
| MIRM | SELL | 2026-03-17 | $7.5M | — | Filing → |